Biostar Pharmaceuticals, Inc.
Biostar Pharmaceuticals, Inc.
Aktie · US0906783016 (OTC)
Übersicht
Kein Kurs
Schlusskurs OTC 27.01.2026: 0,0001 USD
27.01.2026 21:00
Aktuelle Kurse von Biostar Pharmaceuticals, Inc.
BörseTickerWährungLetzter UmsatzKursTagesveränderung
OTC: UTC
UTC
BSPM
USD
27.01.2026 21:00
0,0001 USD
0,00 USD
Firmenprofil zu Biostar Pharmaceuticals, Inc. Aktie
Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company's OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for pain and other symptoms associated with menstruation; Deafness Tongqiao pills for hepatobiliary Huosheng, head swelling, deafness and tinnitus, ear pus, dry stool, and urine-yellow; Wenweishu capsules for the treatment of chronic gastritis and pain of epigastric cold; Zhitongtougu ointment for treating joint pain, swelling, tenderness, or dysfunction; and Chuzhang Zehaifu tablets for cataract. Its prescription pharmaceutical products include Danshen granules; Taohuasan pediatric medicines; Jingang tablets; Danxiang Rhinitis tablets; Yanlixiao capsules; Piracetam tablets; Huangyangning tablets; Hyperthyroidism capsules; Fosfomycin Calcium capsules; Qianlietong capsules; Yituo Erythromycin particles; Danshen tablets; Muxiang Shunqi pills; Sifangwei capsules; and Aspirin Enteric-coated tablets. The company also operates a Website that serves as Internet-based China Hepatitis Internet hospital, which offers HBV patients with information on HBV and treatment options, as well as methods to purchase HBV medicines. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of sales people in approximately 28 provinces. The company was incorporated in 2007 and is headquartered in Xianyang, the People's Republic of China.
KI-Analyse von Biostar Pharmaceuticals, Inc.
Wähle eine Analyse aus und der finAgent liefert dir tiefgehende Einblicke dazu!
Neuste KI Analysen zu Biostar Pharmaceuticals, Inc.
Für dieses Unternehmen sind noch keine KI-Threads verfügbar.

Unternehmensdaten

Name Biostar Pharmaceuticals, Inc.
Firma Biostar Pharmaceuticals, Inc.
Website https://biostarpharmaceuticals.com
Heimatbörse OTC UTC
ISIN US0906783016
Wertpapierart Aktie
Sektor Healthcare
Branche Drug Manufacturers - Specialty & Generic
CEO Ronghua Wang
Land China
Währung USD
Mitarbeiter 0,2 T
Adresse No. 588 Shiji Xi Road, 712000 Xianyang
IPO Datum 2008-12-18

Ticker Symbole

Name Symbol
Over The Counter BSPM
Weitere Aktien
Investoren, die Biostar Pharmaceuticals, Inc. halten, haben auch folgende Aktien im Depot:
INVO Fertility, Inc. - Common Stock
INVO Fertility, Inc. - Common Stock Aktie
WTS LKD A ORDS HENAN DAYOU 26/06/2023
WTS LKD A ORDS HENAN DAYOU 26/06/2023 Verbriefte Derivate
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026